191 related articles for article (PubMed ID: 10537342)
1. Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma.
Bukowski RM; Rayman P; Molto L; Tannenbaum CS; Olencki T; Peereboom D; Tubbs R; McLain D; Budd GT; Griffin T; Novick A; Hamilton TA; Finke J
Clin Cancer Res; 1999 Oct; 5(10):2780-9. PubMed ID: 10537342
[TBL] [Abstract][Full Text] [Related]
2. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils.
Gasperini S; Marchi M; Calzetti F; Laudanna C; Vicentini L; Olsen H; Murphy M; Liao F; Farber J; Cassatella MA
J Immunol; 1999 Apr; 162(8):4928-37. PubMed ID: 10202039
[TBL] [Abstract][Full Text] [Related]
3. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor.
Tannenbaum CS; Tubbs R; Armstrong D; Finke JH; Bukowski RM; Hamilton TA
J Immunol; 1998 Jul; 161(2):927-32. PubMed ID: 9670971
[TBL] [Abstract][Full Text] [Related]
4. Expression of the chemokines IP-10 and Mig in IL-10 transduced tumors.
Sun H; Kundu N; Dorsey R; Jackson MJ; Fulton AM
J Immunother; 2001; 24(2):138-43. PubMed ID: 11265771
[TBL] [Abstract][Full Text] [Related]
5. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells.
Sauty A; Dziejman M; Taha RA; Iarossi AS; Neote K; Garcia-Zepeda EA; Hamid Q; Luster AD
J Immunol; 1999 Mar; 162(6):3549-58. PubMed ID: 10092813
[TBL] [Abstract][Full Text] [Related]
6. Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma.
Dajotoy T; Andersson P; Bjartell A; Löfdahl CG; Tapper H; Egesten A
J Leukoc Biol; 2004 Sep; 76(3):685-91. PubMed ID: 15197236
[TBL] [Abstract][Full Text] [Related]
7. Alloimmune induction of endothelial cell-derived interferon-gamma-inducible chemokines.
Raju R; Malloy A; Shah T; Smith R; Oaks M; Hosenpud JD
Transplantation; 2003 Apr; 75(7):1072-4. PubMed ID: 12698106
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma.
Dorsey R; Kundu N; Yang Q; Tannenbaum CS; Sun H; Hamilton TA; Fulton AM
Cancer Res; 2002 May; 62(9):2606-10. PubMed ID: 11980656
[TBL] [Abstract][Full Text] [Related]
10. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S
J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of alpha-chemokines IP-10, I-TAC, and MIG are differentially regulated in human corneal keratocytes.
McInnis KA; Britain A; Lausch RN; Oakes JE
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1668-74. PubMed ID: 15851567
[TBL] [Abstract][Full Text] [Related]
12. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12.
Tannenbaum CS; Wicker N; Armstrong D; Tubbs R; Finke J; Bukowski RM; Hamilton TA
J Immunol; 1996 Jan; 156(2):693-9. PubMed ID: 8543822
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
[TBL] [Abstract][Full Text] [Related]
14. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in mice.
Rakhit A; Yeon MM; Ferrante J; Fettner S; Nadeau R; Motzer R; Bukowski R; Carvajal DM; Wilkinson VL; Presky DH; Magram J; Gately MK
Clin Pharmacol Ther; 1999 Jun; 65(6):615-29. PubMed ID: 10391667
[TBL] [Abstract][Full Text] [Related]
16. Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma.
Kunz M; Toksoy A; Goebeler M; Engelhardt E; Bröcker E; Gillitzer R
J Pathol; 1999 Dec; 189(4):552-8. PubMed ID: 10629557
[TBL] [Abstract][Full Text] [Related]
17. TNF-alpha is a potent inducer for IFN-inducible protein-10 in hepatocytes and unaffected by GM-CSF in vivo, in contrast to IL-1beta and IFN-gamma.
Narumi S; Yoneyama H; Inadera H; Nishioji K; Itoh Y; Okanoue T; Matsushima K
Cytokine; 2000 Jul; 12(7):1007-16. PubMed ID: 10880246
[TBL] [Abstract][Full Text] [Related]
18. Interferon-inducible protein 10 induction and inhibition of angiogenesis in vivo by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
Cao Z; Baguley BC; Ching LM
Cancer Res; 2001 Feb; 61(4):1517-21. PubMed ID: 11245459
[TBL] [Abstract][Full Text] [Related]
19. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts.
Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C
Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726
[TBL] [Abstract][Full Text] [Related]
20. Human corneal epithelial cells synthesize ELR(-)alpha-chemokines in response to proinflammatory mediators.
McInnis KA; Britain A; Lausch RN; Oakes JE
Ocul Immunol Inflamm; 2007; 15(4):295-302. PubMed ID: 17763126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
